03.04.2012 • NewsCognisLonzaManagement

Lonza Appoints Richard Ridinger as New CEO

At a meeting on 2 April 2012, the Board of Directors of Lonza elected Richard Ridinger as the new CEO of Lonza. Mr. Ridinger, 53, will become CEO of Lonza effective 1 May. Rolf Soiron was acting CEO ad interim, since the end of January.

Richard Ridinger has held numerous leadership functions at Henkel for 14 years and Cognis for 11 years. Most recently, Mr. Ridinger was responsible for Care Chemicals, the largest sector at Cognis with approximately 3,000 employees. During his tenure, sales increased by 60% to €1.75 billion over six years, as he successfully repositioned the business in the market.

At the 2 April meeting, the Board of Directors also appointed Marc Funk, Group General Counsel and Board Secretary, to become a member of the Management Committee. Marc Funk joined Lonza in January 2009; prior he was associate general counsel at Merck Serono.

 

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.